Antibodies against linear epitopes on the goodpasture autoantigen and kidney injury

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 6, 2012, Pages 926-933

  Jia, Xiao Yu ^a   Cui, Zhao ^a   Yang, Rui ^a   Hu, Shui Yi ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CREATININE; EPITOPE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PEPTIDE; PROTEIN P14 ANTIBODY; PROTEIN P16 ANTIBODY; PROTEIN P18 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; KIDNEY INJURY; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; T LYMPHOCYTE;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; COLLAGEN TYPE IV; CREATININE; CROSS REACTIONS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84862203718     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09930911     Document Type: Article

References (33)

1. Goodpasture EW: The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158: 863-870, 1919
2. Wilson CB, Dixon FJ: Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3: 74-89, 1973
3. Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG: Identification of theGoodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263: 13374-13380, 1988
4. Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A, Pusey CD: Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 89: 592-601, 1992
5. Steblay RW, Rudofsky U: In vitro and in vivo properties of autoantibodies eluted from kidneys of sheep with autoimmune glomerulonephritis. Nature 218: 1269-1271, 1968
6. Edgington TS, Glassock RJ, Dixon FJ: Autologous immunecomplex pathogenesis of experimental allergic glomerulonephritis. Science 155: 1432-1434, 1967
7. Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, Hudson BG: The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem 275: 6030-6037, 2000
8. Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG: Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363: 343-354, 2010
9. Vanacore R, Ham AJ, Voehler M, Sanders CR, Conrads TP, Veenstra TD, Sharpless KB, Dawson PE, Hudson BG: A sulfilimine bond identified in collagen IV. Science 325: 1230-1234, 2009
10. Kalluri R, Danoff TM, Okada H, Neilson EG: Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 100: 2263-2275, 1997
11. Sado Y, Naito I, Okigaki T: Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies fromthe urine of nephritic rats. J Pathol 158: 325-332, 1989
12. Kohda T, Okada S, Hayashi A, Kanzaki S, Ninomiya Y, Taki M, Sado Y: High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBMnephritis. Kidney Int 66: 177-186, 2004
13. Reynolds J, Albouainain A, Duda MA, Evans DJ, Pusey CD: Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol Dial Transplant 21: 3398-3408, 2006
14. +) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol 12: 1908-1915, 2001
15. Li S, Holdsworth SR, Tipping PG: Antibody independent crescentic glomerulonephritis in mu chain deficientmice. Kidney Int 51: 672-678, 1997
16. Tipping PG, Huang XR, Qi M, Van GY, Tang WW: Crescentic glomerulonephritis in CD4-and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol 152: 1541-1548, 1998
17. Reynolds J, Tam FW, Chandraker A, Smith J, Karkar AM, Cross J, Peach R, Sayegh MH, Pusey CD: CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest 105: 643-651, 2000
18. Wu J, Hicks J, Borillo J, Glass WF 2nd, Lou YH: CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 109: 517-524, 2002
19. Wu J, Borillo J, Glass WF, Hicks J, Ou CN, Lou YH: T-cell epitope of alpha3 chain of type IV collagen induces severe glomerulonephritis. Kidney Int 64: 1292-1301, 2003
20. Bolton WK, Chen L, Hellmark T, Wieslander J, Fox JW: Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen. J Am Soc Nephrol 16: 2657-2666, 2005
21. Reynolds J, Haxby J, Juggapah JK, Evans DJ, Pusey CD: Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis. Clin Exp Immunol 155: 311-319, 2009
22. Cairns LS, Phelps RG, Bowie L, Hall AM, Saweirs WW, Rees AJ, Barker RN: The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol 14: 2801-2812, 2003
23. Levy JB, Coulthart A, Pusey CD: Mapping B cell epitopes in Goodpasture's disease. J Am Soc Nephrol 8: 1698-1705, 1997
24. Hellmark T, Brunmark C, Trojnar J, Wieslander J: Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides. Clin Exp Immunol 105: 504-510, 1996
25. Phelps RG, Jones VL, Coughlan M, Turner AN, Rees AJ: Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. J Biol Chem 273: 11440-11447, 1998
26. Phelps RG, Jones V, Turner AN, Rees AJ: Properties ofHLA class II molecules divergently associated withGoodpasture's disease. Int Immunol 12: 1135-1143, 2000
27. Zhao J, Cui Z, Yang R, Jia XY, Zhang Y, Zhao MH: Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int 76: 1108-1115, 2009
28. Jayne DR, Marshall PD, Jones SJ, Lockwood CM: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 37: 965-970, 1990
29. Short AK, Esnault VL, Lockwood CM: Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. AmJ KidneyDis 26: 439-445, 1995
30. Phelps RG, Turner AN, Rees AJ: Direct identification of naturally processed autoantigen-derived peptides bound to HLA-DR15. J Biol Chem 271: 18549-18553, 1996
31. Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr: Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 173: 1433-1439, 1991
32. Cui Z, Zhao J, Jia XY, Zhu SN, Zhao MH: Clinical features and outcomes of anti-glomerular basement membrane disease in older patients. Am J Kidney Dis 57: 575-582, 2011
33. Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY: Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 24: 1838-1844, 2009